Mohamad Sebai, MD
Interventional Pain Medicine · Lafayette, INNPI 1700317336
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (57.1%), travel and lodging and grants — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Medtronic at 45.9% of the total.
Across 78 payments — averaging $127.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$5K
- Si-bone, Inc.$1K
- MML US, Inc.$892
- Globus Medical$659
- Boston Scientific$487
- Abbott$390
- plus $2K from 10 others
What the payments were for
- Grants$1,66717%
- Travel & lodging$2,59426%
- Food & beverage$5,66657%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 30 | $4,558 |
| Si-bone, Inc. | 6 | $1,363 |
| MML US, Inc. | 7 | $892 |
| Globus Medical | 8 | $659 |
| Boston Scientific | 5 | $487 |
| Abbott | 3 | $390 |
| Foundation Fusion Solutions, LLC | 3 | $326 |
| Vertos Medical, Inc. | 2 | $285 |
| Biotronik NRO, Inc. | 3 | $207 |
| Nalu Medical, Inc. | 3 | $197 |
| Relievant Medsystems, Inc. | 1 | $161 |
| Nevro Corp. | 1 | $131 |
| SPR Therapeutics, Inc | 3 | $123 |
| Urgo Medical North America, LLC | 1 | $91 |
| Johnson & Johnson | 1 | $40 |
| Stryker | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VANTA ADAPTIVESTIM$1,706
- SYNCHROMEDII$1,667
- IFUSE IMPLANT SYSTEM$1,087
- ReActiv8$804
- Intracept$642
- Senza$558
- INTELLIS ADAPTIVESTIM$452
- PROCLAIM$390
- mild Device Kit$285
- GENERAL PAIN MANAGEMENT$171
- GENERAL - THERAPIES$164
- Prospera$147
How this compares
$9,927 in reported general payments places this provider in the 80th percentile of 68 interventional pain medicine providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pregabalin | 16 | $936 |
| Gabapentin | 32 | $539 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 20 | $490 |
| Duloxetine Hcl | 16 | $218 |
| Cyclobenzaprine Hcl | 23 | $163 |
| Meloxicam | 11 | $13 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Lafayette
- Joseph RutledgeLafayette$96K
- Jennifer EmmertLafayette$3K
- Kelly GrottLafayette$2K
- Shelle SchumacherLafayette$735
- Joshua WellingtonCarmel$315K
- Orlando LandrumElkhart$34K
- Mahendra SanapatiEvansville$31K
- Nikhil ShettyMunster$29K
- David GordonIndianapolis$28K
- Vinayak BelamkarIndianapolis$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.